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mAbstract
Purpose: Adrenomedullin (ADM) has been referred to as a double-edged sword during
septic shock: On one hand, ADM supplementation improved organ perfusion and
function, attenuated systemic inflammation, and ultimately reduced tissue apoptosis
and mortality. On the other hand, ADM overproduction can cause circulatory collapse
and organ failure due to impaired vasoconstrictor response and reduced myocardial
contractility. Since most of these data originate from un-resuscitated shock models, we
tested the hypothesis whether the newly developed anti-ADM antibody HAM1101 may
improve catecholamine responsiveness and thus attenuate organ dysfunction during
resuscitated murine, cecal ligation and puncture (CLP)-induced septic shock.
Methods: Immediately after CLP, mice randomly received vehicle (phosphate-buffered
saline, n = 11) or HAM1101 (n = 9; 2 μg·g−1). Fifteen hours after CLP, animals were
anesthetized, mechanically ventilated, instrumented, and resuscitated with
hydroxyethylstarch and continuous i.v. norepinephrine to achieve normotensive
hemodynamics (mean arterial pressure > 50 to 60 mmHg).
Results: HAM1101 pretreatment reduced the norepinephrine infusion rates required to
achieve hemodynamic targets, increased urine flow, improved creatinine clearance, and
lowered neutrophil gelatinase-associated lipocalin blood levels, which coincided with
reduced expression of the inducible nitric oxide synthase and formation of
peroxynitrite (nitrotyrosine immunostaining) in the kidney and aorta, ultimately
resulting in attenuated systemic inflammation and tissue apoptosis.
Conclusions: During resuscitated murine septic shock, early ADM binding with
HAM1101 improved catecholamine responsiveness, blunted the shock-related
impairment of energy metabolism, reduced nitrosative stress, and attenuated systemic
inflammatory response, which was ultimately associated with reduced kidney
dysfunction and organ injury.
Keywords: Cecal ligation and puncture; Creatinine clearance; Neutrophil gelatinase-
associated lipocalin; Inducible nitric oxide synthase; Endothelial nitric oxide synthase;
Peroxynitrite; Apoptosis2013 Wagner et al.; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
ttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
edium, provided the original work is properly cited.
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Adrenomedullin (ADM) has been referred to as a double-edged sword in sepsis [1]:
during cecal ligation and puncture (CLP)- [2-4], endotoxin- [5], or Staphylococcus
aureus α-toxin-induced sepsis [6], ADM administration restored organ perfusion dur-
ing the hypodynamic shock phase. This effect coincided with attenuated systemic in-
flammation [7], decreased activation of the inducible nitric oxide synthase (iNOS) and
peroxynitrite formation [8], and reduced organ dysfunction [9], apoptosis [10], and
mortality [6]. ADM release is therefore referred to as a protective adaption to systemic
inflammation [11] and circulatory shock [12]. Nevertheless, its overproduction may
cause circulatory collapse and organ failure [13] due to peripheral vasodilation [14]: ar-
terial hypotension and reduced systemic vascular resistance correlated with increased
ADM concentrations in volunteers injected with endotoxin [15] and patients with sep-
sis [16]. Moreover, ADM levels were directly related to morbidity and mortality
[17-21], and persistently high concentrations allowed predicting infectious complica-
tions after septic shock [22]. The ADM-related hypotension results from excess NO re-
lease with impaired vasoconstrictor response [23,24] and myocardial contractility [25].
In un-resuscitated shock, ADM antagonists reversed these effects and ultimately im-
proved survival [24,25]. Hollenberg et al., however, showed that survival of wild-type
and iNOS−/− mice after CLP-induced sepsis only differed when adequate resuscitation
was provided [26]. Therefore, we tested the hypothesis whether a newly developed
ADM antibody may improve catecholamine responsiveness and attenuate kidney dys-
function in resuscitated, CLP-induced septic shock [27].Materials and methods
Anesthesia, surgical instrumentation, and experimental protocol
The study protocol was approved by the University Animal Care Committee and the
federal authorities for animal research of the Regierungspräsidium Tübingen, Baden-
Württemberg. A total of 23 male C57BL/6J mice (body weight 23 to 29 g, age 10 to 16
weeks) were used for the experiments, which were performed in adherence to the
National Institutes of Health Guidelines on the Use of Laboratory Animals. Animals
which did not undergo mechanical ventilation and surgical instrumentation served as
controls for the assessment of blood ADM levels (n = 4) and tissue immune blotting
and gel shifts (n = 6). Immediately after CLP, mice randomly received vehicle (phos-
phate-buffered saline (PBS), n = 11) or the anti-ADM antibody HAM1101 (n = 12;
2 μg·g−1 to achieve antibody concentrations >4 μg·mL−1, i.e., to guarantee plasma anti-
body levels two orders of magnitude in excess of ADM concentrations). HAM1101 is
an antibody directed to the N-terminal part of ADM and was chosen because, in pilot
experiments, it had significantly improved 14-day survival after CLP in mice (n = 10)
with otherwise 100% mortality within two (vehicle PBS) and three (control antibody)
days. Three animals were excluded: at necropsy and organ removal, one animal pre-
sented with pronounced intra-abdominal and retroperitoneal bleeding, and in the two
other animals, by accident, the antibody preparation was not adequately stored within
the specifications. Therefore, statistical analysis in the HAM1101 group refers to n = 9.
The anesthesia, CLP procedure, and the surgical instrumentation have been described
in detail previously [27]. Mice were anesthetized with sevoflurane and s.c. buprenorphine
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ligation and a single puncture (18-gauge needle) were performed. After squeezing to expel
a stool, the cecum was returned into the abdominal cavity. Postoperatively, water and
food were provided ad libitum. After 8 h, mice received a second s.c. injection as de-
scribed above together with buprenorphine, ceftriaxon, and clindamycine. Fifteen hours
post-CLP, mice were anesthetized with sevoflurane, i.p. ketamine, midazolam, and
fentanyl. After placement of the animal on the procedure bench equipped with heating
pads and lamps, a rectal temperature probe was inserted. The anterior neck was incised
to expose the trachea, the right internal jugular vein, and the right carotid artery.
The trachea was intubated, and the lungs were mechanically ventilated with a
pressure-controlled, lung-protective ventilation strategy using a small animal ventila-
tor (FlexiVentTM, Scireq®, Montreal, Canada) [28]. After a lung recruitment maneu-
ver, respirator settings were as follows: FiO2 = 0.5, tidal volume = 6 to 8 μL·g
−1,
respiratory rate = 160 breaths·min−1, inspiratory/expiratory time ratio = 1:2, and
PEEP = 5 cm H2O. Catheters were inserted into the jugular vein, the carotid artery,
and the bladder. Anesthesia was maintained with continuous i.v. ketamine, fentanyl,
and midazolam, titrated to reach deep sedation and analgesia as documented by complete
tolerance against noxious stimuli. Normoglycemia was maintained by i.v. glucose (stable,
non-radioactive labeled 1,2,3,4,5,6-13C6-glucose and unlabeled glucose, 0.5 mg·g
−1·h−1
each). Normotensive hemodynamics (i.e., mean arterial pressure >50 to 60 mmHg) were
achieved by i.v. hydroxyethylstarch (maximum infusion rate 20 μL·g−1·h−1) and, if needed,
together with norepinephrine. After 5 h, animals were killed through blood withdrawal
via the V. cava inferior.Nitrate, cytokine, and chemokine concentrations
As a surrogate for NO production, plasma nitrite + nitrate (NO2
−+NO3
−) levels were
measured using chemiluminescence after reduction to NO with vanadium chloride
(NOA 280 NO Analyzer, Sievers Medical Instruments, Boulder, CO, USA) [29]. Plasma
tumor necrosis factor (TNF)-α, interleukin (IL)-6, monocyte chemoattractant protein
(MCP)-1, and keratinocyte-derived chemokine (KC) concentrations were determined
using a mouse multiplex cytokine kit (Bio-Plex Pro Cytokine Assay, Bio-Rad, Hercules,
CA, USA). The assay was performed by using the Bio-Plex suspension array system ac-
cording to the manufacturer's instructions [27,28]. Levels below the detection limit of
the assays were set to zero for statistical purposes.Adrenomedullin assay and adrenomedullin antibody (HAM1101) preparation
The detailed description is presented as an Additional file 1. Briefly, plasma ADM (both
free and antibody-bound ADM in the HAM1101 group) concentrations were measured
with a sandwich coated tube luminescence immunoassay, based on acridinium NHS-
ester labeling and anti-mouse ADM antibodies (MAM). Dilutions of mouse adrenome-
dullin (mADM) and subsequently the labeled tracer MAM1301 were added to
MAM1201-coated tubes. After washing of unbound tracer, chemiluminescence was
measured (AutoLumat LB 953 Berthold Technologies, Bad Wildbad, Germany). For
antibody preparation, murine and human ADM peptides were synthesized (JPT Tech-
nologies, Berlin, Germany) with an additional N-terminal cysteine (if no cysteine is
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peptides to bovine serum albumin using SulfoLink-coupling gel (Perbio Science, Bonn,
Germany). HAM1101 blood concentrations were quantified via competitive immuno-
assay employing chemoluminescence-labeled HAM1101 as tracer and ADM in the
solid phase.Creatinine, urea, and neutrophil gelatinase-associated lipocalin
Blood neutrophil gelatinase-associated lipocalin (NGAL) concentrations were measured
using a commercial ELISA (mouse NGAL, RUO 042, BioPorto Diagnostics A/S,
Gentofte, Denmark). Urea and creatinine concentrations were quantified with a capil-
lary column (Optima-5MS, Macherey-Nagel, Düren, Germany) gas chromatography/
mass spectrometry system (Agilent 5890/5970, Böblingen, Germany) using 2H3-creatinine
(CDN isotopes, Pointe-Claire, QU, Canada) and methylurea (Fluka Chemikalien,
Buchs, Switzerland) as internal standards. After deproteinization with acetonitrile
and evaporation to dryness, the supernatant was reconstituted in formic acid and ex-
tracted over a weak anion exchange column (WCX, Phenomenex, Aschaffenburg,
Germany). Acetonitrile plus N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide
and N,O-bis(trimethylsilyl)trifluoroacetamide allowed formation of the urea tert-
butyl-dimethylsilyl- and the creatinine trimethylsilyl-derivatives, respectively. Ions
m/z 231 and 245, and m/z 329 and 332 were monitored for urea and creatinine ana-
lytes and internal standards. Creatinine clearance was derived from urine output and
plasma and urine creatinine concentrations.Glucose metabolism
Parameters of glucose metabolism were determined using gas chromatography/mass
spectrometry [30]. After conversion of glucose to a penta-trifluoroacetyl derivative, en-
dogenous glucose production rate was calculated from the blood 13C6-glucose isotope
enrichment. Whole-body glucose oxidation was derived from the total CO2 production
and the 13CO2/
12CO2 isotope ratio in the mixed expiratory gas.Cell extracts, electrophoretic mobility shift assay, immunoblots, and comet assay
Immediately postmortem, the right kidney was removed, homogenized, and lysed in
lysing buffer. Cells were resuspended and lysed on ice. To assess the expression of
heme oxygenase-1 (HO-1), activated caspase-3, and BcL-xL, equal total protein aliquots
(20 to 60 μg) were separated by SDS-PAGE and transferred by Western blotting. After
blocking, the membranes were incubated with primary antibodies (anti HO-1, Stress-
gen; anti-Bcl-xL, anti-cleaved caspase-3, Cell Signaling, Danvers, MA, USA). The pri-
mary antibodies were detected using horseradish peroxidase-conjugated secondary
antibodies (Cell Signaling or Santa Cruz, Heidelberg, Germany). The membranes were
subjected to chemiluminescence using the SuperSignal West Femto Maximum Sen-
sitivity Substrate (Thermo Scientific, Ulm, Germany). Exposed films were scanned,
and intensity of immunoreactivity was measured using NIH ImageJ software (http://
rsb.info.nih.gov/nih-image). Activation of the nuclear transcription factor κB (NF-κB)
was determined using an electrophoretic mobility shift assay (EMSA) [27,28]: cell extracts
were incubated with poly-doxy-inosinic-deoxy-cytidylic acid (poly-dI-dC) and 32P-labeled
Wagner et al. Journal of Software Engineering Research and Development 2013, 1:2 Page 5 of 15
http://www.icm-experimental.com/content/1/1/2double stranded oligonucleotide containing the NF-κB (HIVκB-site) (5′-GGATCCTCAA
CAGAGGGGACTTTCCGAGGCCA-3′). Complexes were separated in polyacrylamide
gels and exposed to X-ray films. A phosphorimager and image analysis software allowed
quantifying the radioactively labeled NF-κB. Relating the intensity of each band to that of
control animals loaded simultaneously allowed for comparison between individual gels.
Protein expression and NF-κB activation are presented as x-fold increase over control
values.
Single cell gel electrophoresis allowed assessing the oxidative deoxyribonucleic acid
(DNA) damage (‘tail moment’ in the alkaline version of the comet assay) [30]. Immediate
postmortem biopsies were placed in buffer containing Na-ethylenediaminetetraacetic acid
and minced to obtain a cell suspension. Two agarose gel slides were prepared from each
biopsy. The mean tail moment of 100 nuclei analyzed per slide was used for each animal.Histology
Immediately postmortem, the left kidney was removed, sectioned by a sagittal cut, and
fixed in paraformaldehyde for histopathological examination by an experienced path-
ologist (A.S.) blinded for the sample grouping. Paraffin sections were stained with
hematoxylin and eosin and periodic acid-Schiff staining; photomicrographs were taken
of three sampling areas from each section. Glomerular histopathological alterations
were analyzed for glomerular tubularization, i.e., the herniation of proximal tubular
epithelial cells into Bowman's capsule [31]. Data are expressed as the number of glom-
eruli showing glomerular tubularization in percentage of all glomeruli analyzed (outer
cortical region 30, medullar region 20 glomeruli) of the three random sections. Tubular
histopathological damage was assessed as intraluminal protein cylinders and necrosis.Immunohistochemistry for nitrotyrosine and the inducible nitric oxide synthase
The descending thoracic aorta was excised down to the diaphragm, fixed in paraformal-
dehyde, and embedded in paraffin. Sections of the aorta and the left kidney were
dewaxed in xylene, rehydrated with ethanol, incubated in citrate buffer, brought to boil-
ing for heat-induced antigen retrieval, and blocked with goat sera before incubation
with rabbit anti-nitrotyrosine 1:250 (Millipore #-AB5411, Schwalbach, Germany), anti-
eNOS (eNOS BD# 610297, Beckton Dickinson, Heidelberg, Germany), and anti-iNOS
(Santa Cruz #sc-651). Primary antibody detection was performed with anti-rabbit Dako
Real detection system alkaline phosphatase red (Dako #K5005, Copenhagen, Denmark).
Slides were visualized using a Zeiss Axio Imager A1 microscope. Five artery and three
kidney sections were quantified for intensity and area of the immune-reactive regions
using the AxioVision (rel. 4.8) software (Zeiss, Jena, Germany). Results are presented as
arbitrary units of densitometric sum red.Statistical analysis
All data are presented as median (range). After exclusion of normal distribution using
the Kolmogorov-Smirnov test, differences between groups were analyzed with a one-way
Kruskal-Wallis analysis of variance on ranks followed by a post hoc Dunn test. Because of
the multiple statistical testing resulting from the numerous variables measured, all results
have to be interpreted in an exploratory rather than confirmatory manner.
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Plasma ADM concentrations in mice without mechanical ventilation and surgical in-
strumentation were 7 (4, 11) pg·mL−1. HAM1101 tended to attenuate the CLP-induced
increase in ADM levels, however, without reaching statistical significance (p = 0.094;
Table 1). The total, i.e., crystalloid plus colloid, fluid infusion rate was identical (vehicle
48 (47, 50), HAM1101 47 (46. 49) μL·g−1·h−1, p = 0.185) in the two groups. All animals
needed continuous i.v. noradrenaline to achieve hemodynamic targets, and HAM1101
was associated with significantly lower mean infusion rates during the 5-h observation
period (0.010 (0.09, 0.012) vs. 0.019 (0.016, 0.24) μg·g−1·h−1, p < 0.001). In all 23 animals
taken together, i.e., also taking into account the three animals excluded from the de-
tailed statistical analysis, there was a significant linear relationship between the ADM
blood levels and the noradrenaline infusion rates (Pearson coefficient of correlation
r2 = 0.574, p < 0.001) (Figure 1).
Hemodynamics, gas exchange, acid-base status, glycemia, endogenous glucose, or
total CO2 production did not differ between the two groups (Table 2). However,
HAM1101 lowered lactatemia and increased direct, aerobic glucose oxidation until the
end of the experiment. HAM1101 was associated with three- and twofold higher diur-
esis and creatinine clearance, (Table 3), respectively, ultimately resulting in lower cre-
atinine, urea, and NGAL concentrations. HAM1101 caused a two- to tenfold reduction
of the blood levels of IL-10 and the pro-inflammatory cytokines and chemokines,
whereas NO2
− + NO3
− concentrations did not differ (Table 4).
Figure 2 shows the results of immune blotting and gel shifts: while NF-κB activation
(Figure 2A) was comparable, HAM1101 attenuated the expression of HO-1 (Figure 2B)
and activated caspase 3 (Figure 2C). In contrast, Bcl-xL expression and the tail moment
in the comet assay did not differ (p = 0.149 and 0.527, respectively; data not shown).
Figures 3 and 4 present typical kidney iNOS (Figure 3, upper panel) and nitrotyrosine
(Figure 4, upper panel) immunostainings. Quantitative analysis (lower panel) showed
that HAM1101 attenuated iNOS activation and nitrotyrosine formation. Figures 5, 6,
and 7 present typical aortic eNOS (Figure 5, upper panel), iNOS (Figure 6, upper panel),
and nitrotyrosine (Figure 7, upper panel) immunostainings. Image analysis demon-
strates that HAM1101 attenuated iNOS activation and nitrotyrosine formation (Figures 6
and 7, lower panel), whereas eNOS expression was comparable (Figure 5, lower panel).
There was only minor kidney histological damage: glomerular tubularization was moder-
ate without intergroup difference (vehicle: 13 (12, 14), HAM1101: 13 (9, 15) % of glomerula
analyzed, p = 0.724), and neither tubular protein cylinders nor necrosis were found.
Discussion
The aim of this study was to test the hypothesis whether the ADM antibody HAM1101
may improve catecholamine responsiveness and attenuate kidney dysfunction duringTable 1 Plasma concentrations of mADM and HAM1101 in vehicle- (n = 11) and
HAM1101-treated (n = 9) animals
Vehicle HAM1101 p value
mADM (pg·mL−1) 96 (37, 190) 33 (21, 64) 0.094
HAM1101 (μg·mL−1) Ø 5.0 (4.2, 6.5) <0.001
Blood samples were taken at the end of the experiment. All data are median (quartiles).
Figure 1 Mean noradrenaline (NoA, μg·g−1·h−1) infusion rates. The infusion rates were plotted as a
function of the blood adrenomedullin (ADM, pg·mL−1) concentrations in all 23 animals taken
together, i.e., also taking into account the three animals excluded from the detailed statistical
analysis because of abdominal bleeding and inadequate antibody activity. The Pearson coefficient of
correlation was r2 = 0.574 (p < 0.001).
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HAM1101 (1) reduced the catecholamine infusion rates needed to maintain target
hemodynamics and (2) improved renal function, which was associated with (3) attenu-
ated systemic inflammation, iNOS activation, and peroxynitrite formation, (4) ultim-
ately resulting in reduced apoptosis.
In the HAM1101-treated mice, the lower noradrenaline requirements coincided with
reduced aortic immunostaining for iNOS and nitrotyrosine, whereas eNOS expression
was unchanged. This finding fits well with previous studies on the interaction of iNOS
and ADM: in vascular smooth muscle cells, ADM aggravated the cytokine-induced
iNOS activation and the excess NO release [23]. In vivo ADM increased myocardial
and coronary endothelial nitrotyrosine formation, which was prevented by the NOS in-
hibitor NG-nitro-L-arginine [32]. ADM antagonism reversed the lipopolysaccharide
(LPS)-induced hypotension in rats [24], ultimately resulting in prolonged survival [25].
Furthermore, during rodent and human endotoxemia, hemodynamic stabilization with
activated protein C was associated with lower blood NO and ADM levels [15]. Finally,
we showed in CLP-induced septic shock that genetic deletion and selective pharmaco-
logical inhibition of iNOS improved catecholamine responsiveness: maintenance of tar-
get hemodynamics was achieved using lower noradrenaline infusion rates [29].
Nevertheless, our current findings may be regarded as in contrast to those of Talero
et al. [8], who reported that ADM dose-dependently reduced iNOS expression, nitrotyr-
osine formation, NF-κB activation, pro-inflammatory cytokine concentrations, and at-
tenuated histological injury in murine acute lung injury. We can only speculate on this
discrepancy, but these authors used a short-term, un-resuscitated, sterile model in
spontaneously breathing mice, whereas we investigated resuscitated polymicrobial
Table 2 Lung mechanics, hemodynamics, gas exchange, acid-base status, and metabolic
parameters
Vehicle HAM1101 p value
Hemoglobin content (mg·mL−1) Start 90 (87, 96) 98 (95, 105) 0.074
End 70 (66, 72) 69 (66, 74) 0.806
Heart rate (beats·min−1) Start 494 (485, 515) 430 (406, 480) 0.248
End 426 (406, 445) 391 (349,430) 0.290
Mean arterial pressure (mmHg) Start 69 (65, 71) 69 (66, 76) 0.382
End 64 (59, 69) 67 (66, 72) 0.441
Thoracopulmonary compliance (μL·cm H2O−1) Start 0.10 (0.09, 0.10) 0.10 (0.09, 0.11) 0.382
End 0.09 (0.08, 0.10) 0.10 (0.08, 0.11) 0.427
Arterial PO2 (mmHg) Start 314 (293, 330) 340 (321, 350) 0.254
End 309 (287, 326) 301 (287, 319) 0.838
Arterial PCO2 (mmHg) Start 31 (27, 33) 31 (29, 36) 0.879
End 34 (33, 36) 31 (28, 33) 0.072
Arterial pH Start 7.33 (7.30, 7.35) 7.36 (7.32, 7.38) 0.569
End 7.38 (7.31, 7.43) 7.43 (7.39, 7.46) 0.253
Arterial base excess (mmol·mL−1) Start −9.0 (−10.3, −7.7) −6.8 (−8.3, −6.2) 0.403
End −5.7 (−7.1, −1.7) −3.9 (−4.2, −3.3) 0.838
Arterial lactate (mmol·mL−1) Start n.d. n.d. n.d.
End 2.0 (1.7, 2.2) 1.6 (1.5, 1.8) 0.025
Arterial glucose (mg·dL−1) Start 113 (110, 117) 115 (106, 123) 0.540
End 110 (96, 117) 111 (109, 115) 0.653
CO2 production rate (μL·g−1·min−1) Start 26 (24, 28) 24 (23, 25) 0.082
End 23 (21, 26) 23 (22, 25) 0.596
Glucose production rate (mg·g−1·h−1) Start 0.37 (0.35, 0.41) 0.34 (0.31, 0.36) 0.178
End 0.38 (0.35, 0.39) 0.33 (0.31, 0.39) 0.153
Glucose oxidation rate (% isotope infusion) Start 58 (55, 62) 55 (50, 59) 0.224
End 57 (54, 60) 62 (58, 67) 0.047
The data are for the vehicle-treated (n = 11) and HAM1101-treated (n = 9) animals at the start and the end of the 5-h
observation period; n.d., not determined. All data are median (quartiles).
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duced cytokine concentrations seem to be in contrast with the unchanged NF-κB acti-
vation. The timing of the measurements most likely matters in this context: We
obtained tissue samples at 20 to 22 h after induction of CLP, and we previously demon-
strated that NF-κB activation was increased at 3 and 6 h and subsequently decreased atTable 3 Parameters of kidney function in the vehicle- (n = 11) and HAM1101-treated
(n = 9) animals
Vehicle HAM1101 p value
Urine output (μL·g−1·h−1) 4.4 (3.5, 16.5) 15.2 (13.9, 22.5) 0.033
Creatinine clearance (μL·min−1) 197 (110, 301) 400 (316, 509) 0.006
Creatinine (μg·mL−1) 1.83 (1.52, 3.04) 1.28 (1.20, 1.52) 0.010
Urea (μg·mL−1) 378 (268, 513) 175 (101, 184) 0.004
NGAL (μg·mL−1) 16 (15, 20) 11 (10, 13) 0.008
Blood concentrations were measured in samples taken at the end of the experiment. NGAL, neutrophil gelatinase-
associated lipocalin. All data are median (quartiles).
Table 4 Blood nitrite + nitrate (NO2
− + NO3
−, in nmol·mL−1), cytokine, and chemokine
concentrations
Vehicle HAM1101 p value
NO2
− + NO3
− 111 (59, 121) 92 (47, 93) 0.170
TNF-α 32 (13, 62) 1 (0, 8) 0.010
IL-6 363 (120, 681) 43 (22, 55) 0.002
IL-10 33 (10, 81) 3 (2, 6) 0.004
KC 2923 (1873, 7138) 650 (516, 1577) 0.016
MCP-1 1130 (779, 1738) 509 (335, 614) 0.005
The data are for vehicle-treated (n = 11) and HAM1101-treated (n = 9) animals. Blood samples were taken at the end of
the experiment. TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; IL-10, interleukin-10; KC, keratinocyte-derived
chemokine; MCP-1, monocyte chemoattractant protein-1. All parameters are in pg·mL−1. All data are median (quartiles).
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gers not only inflammation but also its resolution [34], and the present finding well
agrees with previous data on the effect of combining Na2S and hypothermia in the
same model: the lowest pro-inflammatory cytokine plasma and tissue concentrations
and the highest blood IL-10 levels coincided with the maximum NF-κB activation [27].
Interestingly, HAM1101 reduced iNOS expression and nitrotyrosine formation but
did not affect vascular eNOS expression. Moreover, ADM plasma concentrations were
not significantly reduced either, the mean value in the HAM1101-treated animals being
five times higher than in mice without surgery. This finding fits with Gupta et al.BA
C
Figure 2 Representative gel shifts and immune blots. Also included is the quantitative analysis of the
activation of the nuclear transcription factor κB (NF-κB) (A) and the tissue expression of heme oxygenase-1 (HO-1)
(B) and cleaved caspase-3 (C) from immediate postmortem kidney specimen in the vehicle-treated (open box
plots, n = 11) and HAM1101-treated (grey box plots, n = 9) mice. Data reported are median, quartiles, and range
and refer to fold increase of values from animals which had only undergone surgical instrumentation (‘control’).
Figure 4 Renal nitrotyrosine immunostaining. Examples (magnification ×20) of the renal nitrotyrosine
immunostaining from the immediate postmortem kidney specimen in the vehicle (upper left panel) and
HAM1101 (upper right panel) as well as results of the quantitative image analysis (vehicle group: open box
plots, n = 11; HAM1101 group: grey box plots, n = 9). Data reported are median, quartiles, and range.
Figure 3 Renal iNOS immunostaining. Examples (magnification ×20) of the renal iNOS immunostaining
from the immediate postmortem kidney specimen in the vehicle (upper left panel) and HAM1101 (upper
right panel) as well as results of the quantitative image analysis (vehicle group: open box plots, n = 11;
HAM1101 group: grey box plots, n = 9). Data reported are median, quartiles, and range.
Wagner et al. Journal of Software Engineering Research and Development 2013, 1:2 Page 10 of 15
http://www.icm-experimental.com/content/1/1/2
Figure 5 Thoracic aortic eNOS immunostaining. Examples (magnification ×40) of the thoracic aortic eNOS
immunostaining from the immediate postmortem kidney specimen in the vehicle (upper left panel) and
HAM1101 (upper right panel) as well as results of the quantitative image analysis (intima layer; vehicle group:
open box plots, n = 11; HAM1101 group: grey box plots, n = 9). Data reported are median, quartiles, and range.
Figure 6 Thoracic aortic iNOS immunostaining. Examples (magnification ×40) of the thoracic aortic iNOS
immunostaining from the immediate postmortem kidney specimen in the vehicle (upper left panel) and HAM1101
(upper right panel) as well as results of the quantitative image analysis (intima plus media layer; vehicle group: open
box plots, n = 11; HAM1101 group: grey box plots, n = 9). Data reported are median, quartiles, and range.
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Figure 7 Thoracic aortic nitrotyrosine immunostaining. Examples (magnification ×40) of the thoracic
aortic nitrotyrosine immunostaining from the immediate postmortem kidney specimen in the vehicle
(upper left panel) and HAM1101 (upper right panel) as well as results of the quantitative image analysis
(intima plus media layer; vehicle group: open box plots, n = 11; HAM1101 group: grey box plots, n = 9).
Data reported are median, quartiles, and range.
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complete reversal of the LPS-induced increase in blood NO and ADM levels [15]. It is
tempting to speculate that HAM1101 attenuated excess NO and ADM formation ra-
ther than completely blocking it while maintaining the constitutive production neces-
sary for organ homoeostasis [9,12]. Clearly, the attenuated iNOS activation is not
mirrored by reduced NO2
− + NO3
− levels. Because of the limited blood volume available,
these values were only obtained at the end of the experiment, i.e., at approximately 22
h after CLP induction. Hence, this finding well fits with previous studies by others and
ourselves that NO2
− + NO3
− concentrations were comparable at 18 to 24 h post-CLP in
mice with ascorbate- [35] or GW274150-induced iNOS inhibition [29] and peroxyni-
trite blockade [36].
We did not measure the degree of interstitial edema; however, the threefold higher
urine output together with the identical fluid administration rates and total hemoglobin
content suggest that HAM1101 attenuated a possible ADM-related fluid extravasation
[37]. Consequently, HAM1101 most likely allowed for better maintenance of circulating
blood volume. The higher urine output coincided with improved creatinine clearance
and lower blood creatinine, urea, and NGAL levels. This evidence of improved glom-
erular and tubular function [38] was associated with reduced iNOS expression and
nitrotyrosine formation, a well-established marker of peroxynitrite formation. Both
iNOS activation and peroxynitrite production play a crucial role for acute kidney injury:
selective iNOS blockade and catalytic peroxynitrite decomposition attenuated kidney
dysfunction and organ damage in murine CLP-induced sepsis [36,39,40]. It could be
Wagner et al. Journal of Software Engineering Research and Development 2013, 1:2 Page 13 of 15
http://www.icm-experimental.com/content/1/1/2argued that the improved renal function is not mirrored by kidney histology: in fact,
tubular necrosis was absent, and glomerular tubularization was only moderate. None-
theless, the reduced expression of activated caspase 3 suggests less apoptosis. Moreover,
we investigated anesthetized and mechanically ventilated mice receiving fluid resuscita-
tion and noradrenaline to maintain normotensive hemodynamics: in un-resuscitated
murine CLP-induced septic shock of comparable duration (18 to 20 h), histological dam-
age coincided with five- to tenfold higher creatinine and urea blood levels [41]. Finally,
more advanced glomerular tubularization was present only after 2 to 3 days and severe
kidney dysfunction with at least ten times higher creatinine levels [38].
Albeit noradrenaline infusion rates were lower; HAM1101 was associated with com-
parable endogenous glucose production. Together with the reduced iNOS expression,
this finding is in line with our previous study in mice with genetic deletion and selective
pharmacological inhibition of iNOS: hepatic gluconeogenesis was comparable despite
lower noradrenaline infusion rates, indicating improved hepatic metabolic performance
[42]. HAM1101 was associated not only with well-maintained glucose formation but
also with a higher direct, aerobic glucose oxidation rate. We could not measure whole-
body O2 uptake, but together with the identical total CO2 production and the compar-
able endogenous glucose production rate, this finding indicates that HAM1101 caused a
preferential use of glucose for energy metabolism. Such a switch in fuel utilization is as-
sociated with an improved yield of oxidative phosphorylation [43]: The ratio of ATP syn-
thesis/oxygen consumption ratio is higher for glycolysis than for β-oxidation because
nicotinamide adenine dinucleotide (NADH) as an electron donor provides three coup-
ling sites rather than two only from flavin adenine dinucleotide (FADH2) [44].
Limitations of the model
HAM1101 was administered immediately after the CLP procedure. Hence, HAM1101
may only be efficacient when administered during the very early phase of sepsis. Conse-
quently, further studies are warranted on the time dependency of the HAM1101
treatment.
All mice needed noradrenaline to maintain target hemodynamics. Consequently, any
beneficial effects of HAM1101 may have been caused by ADM binding per se or due to
this reduction in catecholamine requirements: noradrenaline may exert cardio- and
hepatotoxic effects, enhance systemic inflammation and promote oxidative stress, and
impair mitochondrial respiration.
Conclusions
During resuscitated, polymicrobial, murine septic shock, early ADM binding using the
newly developed N-terminal anti-ADM antibody HAM1101 improved catecholamine
responsiveness and blunted the shock-related impairment of energy metabolism ultim-
ately coinciding with attenuated kidney dysfunction and organ injury. These beneficial
effects of HAM1101 resulted from attenuation of the systemic inflammatory response
and reduced nitrosative stress while constitutive NO synthesis was unaffected.
Additional file
Additional file 1: Supplement. Adrenomedullin (ADM) and ADM antibody (HAM1101) preparation.
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